natgillin/translations-raw huggingface dataset:
Cases of thrombotic microangiopathy, including thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome (TTP/HUS) have been reported in patients who received Kyprolis.
Med zdravljenjem z zdravilom Kyprolis so poročali o primerih trombotične mikroangiopatije, vključno s trombotično trombocitopenično purpuro in hemolitično-uremičnim sindromom (TTP/HUS - thrombocytopenic purpura and haemolytic uraemic syndrome).
Cases of TLS, some fatal, have been rarely observed in clinical trials and have been reported in post-marketing experience in patients treated with sunitinib.
Primere TLS, nekatere s smrtnim izidom, so redko opazili v kliničnih preskušanjih ter o njih poročali v obdobju trženja zdravila pri bolnikih, zdravljenih s sunitinibom.
Cases of TMA, manifested as thrombotic thrombocytopenic purpura (TTP) or haemolytic uraemic syndrome (HUS), including fatal cases, have been reported with interferon beta products.
Pri uporabi zdravil z interferonom beta so poročali o primerih TMA, ki se kažejo kot trombotična trombocitopenična purpura (TTP) ali hemolitični uremični sindrom (HUS), vključno s smrtnimi primeri.
Cases of transient cutaneous reactions (side effects on your skin).
Primeri prehodnih kožnih reakcij (neželeni učinki na vaši koži).
Cases of Viramune overdose at doses ranging from 800 to 6,000 mg per day for up to 15 days have been reported.
Poročajo o dajanju prevelikih odmerkov zdravila Viramune v razponu od 800 do 6000 mg na dan do 15 dni.
Cases of Vogt-Koyanagi-Harada (VKH) syndrome have been reported in patients with chronic hepatitis C treated with interferon.
Pri bolnikih s kroničnim hepatitisom C, ki so se zdravili z interferonom, so poročali o primerih Vogt-Koyanagi-Harada (VKH) sindroma.
Cases of Vogt-Koyanagi-Harada syndrome have been reported post-marketing (see section 4.8).
Po prihodu zdravila na trg so poročali o primerih Vogt-Koyanagi-Haradovega sindroma (glejte poglavje 4.8).
Cases of VTE, including cases of pulmonary embolism and cases of deep vein thrombosis, have been reported with antipsychotic medicinal products.
Pri antipsihotikih so poročali o primerih venske trombembolije, vključno s primeri pljučne embolije in globoke venske tromboze.
Cases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers, including Simponi.
Pri uporabi zaviralcev TNF, vključno z zdravilom Simponi, so poročali o primerih poslabšanja kongestivnega srčnega popuščanja (CHF) in novonastalega kongestivnega srčnega popuščanja.
Cases of worsening congestive heart failure have also been reported in patients receiving Humira.
O primerih poslabšanja kongestivnega srčnega popuščanja so poročali pri bolnikih, ki so prejemali zdravilo Humira.
Cases of worsening congestive heart failure have also been reported in patients receiving Trudexa.
O primerih poslabšanja kongestivnega srčnega popuščanja so poročali pri bolnikih, ki so prejemali Trudexo.
Cases ofpersisting alopecia have been reported.
Opisani so bili primeri persistentne alopecije.
Cases reported in clinical studies in asthma
Prijavljeni primeri v kliničnih študijah pri bolnikih z astmo
Cases suggestive of positive rechallenge were observed.
Opažali so primere, ki so govorili v prid ponovnemu zvišanju transaminaz ob ponovni uvedbi zdravila.
Cases were managed with excision and patients continued treatment without dose adjustment.
Bolnike s takšnimi primeri so zdravili z ekscizijo, bolniki pa so nadaljevali z zdravljenjem brez prilagoditve odmerka.
Cases with fatal outcome have been observed in post-marketing setting (see respiratory events and section 4.8).
Smrtne izide so zabeležili v obdobju trženja (glejte Dogodki na dihalih in poglavje 4.8).
Caspofungin
ciprofloksacin
Caspofungin Accord 50 mg powder for concentrate for solution for infusion
Kspofungin Accord 50 mg prašek za koncentrat za raztopino za infundiranje
Caspofungin Accord 50 mg powder for concentrate for solution for infusion caspofungin
Kaspofungin Accord 50 mg prašek za koncentrat za raztopino za infundiranje kaspofungin
Caspofungin Accord 50 mg powder for concentrate for solution for infusion Each vial contains 50 mg caspofungin (as acetate).
Kaspofungin Accord 50 mg prašek za koncentrat za raztopino za infundiranje Ena viala vsebuje 50 mg kaspofungina (v obliki acetata).
Caspofungin Accord 70 mg powder for concentrate for solution for infusion
Kaspofungin Accord 70 mg prašek za koncentrat za raztopino za infundiranje
Caspofungin Accord 70 mg powder for concentrate for solution for infusion caspofungin
Kaspofungin Accord 70 mg prašek za koncentrat za raztopino za infundiranje kaspofungin
Caspofungin Accord can be added to a reduced volume of 0.9 %, 0.45 %, or 0.225 % Sodium Chloride solution for infusion or Lactated Ringers solution for infusion, not to exceed a final concentration of 0.5 mg/mL.
Druga možnost je, da količino (ml)c pripravljene raztopine zdravila Kaspofungin Accord dodate zmanjšani količini 0,9 %, 0,45 % ali 0,225 % raztopine natrijevega klorida za infundiranje ali raztopine Ringerjevega laktata za infundiranje, vendar končna koncentracija ne sme preseči 0,5 mg/ml.
Caspofungin Accord has not been studied in pregnant women.
Uporabe zdravila Kaspofungin Accord pri nosečnicah niso preučevali.
Caspofungin Accord is a ‘generic medicine’.
Zdravilo Caspofungin Accord je „generično zdravilo“.
Caspofungin Accord is formulated to provide the full labeled vial dose (50 mg) when 10 mL is withdrawn from the vial.
Zdravilo Kaspofungin Accord je pripravljeno tako, da zagotavlja polni, na viali označeni odmerek (50 mg), če iz viale potegnete 10 ml.
Caspofungin Accord is formulated to provide the full labeled vial dose (70 mg) when 10 mL is withdrawn from the vial.
Zdravilo Kaspofungin Accord je pripravljeno tako, da zagotavlja polni, na viali označeni odmerek (70 mg), če iz viale potegnete 10 ml.
Caspofungin Accord is formulated to provide the full labelled vial dose (70 mg) when 10 mL is withdrawn from the vial.
Zdravilo Kaspofungin Accord je pripravljeno tako, da zagotavlja polni, na viali označeni odmerek (70 mg), če iz viale potegnete 10 ml.
Caspofungin Accord is used to treat the following infections in children, adolescents and adults: serious fungal infections in your tissues or organs (called ‘invasive candidiasis’).
Zdravilo Kaspofungin Accord se uporablja za zdravljenje naslednjih okužb pri otrocih, mladostnikih in odraslih: resnih glivnih okužb v vaših tkivih ali organih (imenovanih "invazivna kandidaza").
Caspofungin Accord powder for concentrate for solution for infusion is a white to off-white powder.
Kaspofungin Accord prašek za koncentrat za raztopino za infundiranje je bel do skoraj bel prašek.
Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast.
Kaspofunginijev acetat zavira sintezo beta (1,3)-D- glukana, ki je bistvena sestavina celične stene številnih filamentoznih gliv in kvasovk.
Caspofungin was negative in in vitro assays for potential genotoxicity as well as in the in vivo mouse bone marrow chromosomal test.
Izidi poskusov in vitro za določanje morebitne genotoksičnosti, kakor tudi in vivo kromosomskega testa na kostnem mozgu miši, so bili negativni.
Castleford, West Yorkshire, WF10 5HX United Kingdom
Castleford, West Yorkshire, WF10 5HX Velika Britanija
Castleman’s disease is a disorder of the lymphatic system (a network of vessels that transport fluid from tissues through the lymph nodes and into the bloodstream) in which cells in lymph nodes start growing abnormally, causing benign tumours.
Castlemanova bolezen je bolezen limfatičnega sistema (tj. mreža žil, ki prenašajo tekočino iz tkiv skozi bezgavke v krvni obtok), pri kateri celice v bezgavkah začnejo nenormalno rasti in s tem povzročijo nastanek benignih tumorjev.
Castleman’s disease, who are candidates to receive Sylvant or are
Castelmanovo boleznijo, primernih za zdravljenje z zdravilom
Cat vaccination during and after VIRBAGEN OMEGA treatment is contra-indicated as both FeLV and FIV infections are known to be immunosuppressive.
Cepljenje mačk med in po zdravljenju z VIRBAGEN OMEGA je kontraindicirano, ker sta, FeLV in FIV , imunosupresivni.
Cat weight
Telesna teža mačke
Cat Weight (kg)
Mačke Teža (kg)
Cat: as vaccination is contra-indicated in symptomatic phase of FeLV/FIV infections, effect of VIRBAGEN OMEGA on cat vaccination has not been evaluated.
Mačke: ker je cepljenje v simptomatski fazi okužbe s FeLV/FIV kontraindicirano, vpliv VIRBAGEN OMEGA na cepljenje mačk ni ocenjen.
Cataplexy
katapleksija
Cataplexy Attacks
kataplektični napadi
Cataplexy attacks frequency in patients displaying this symptom was decreased significantly (p=0.034) with pitolisant (-65%) compared to placebo (-10%).
Pogostnost napadov katapleksije pri bolnikih z zadevnimi simptomi se je pri pitolizantu pomembno zmanjšala (–65 %) v primerjavi s placebom (–10 %) (p = 0,034).
Cataract
hipokalciemija
Cataract
katarakta,
cataract
očesna mrena
cataract (clouding of the lens in the eye)
katarakta (motnost očesne leče),
Cataract (cloudy lens in the eye).
katarakta (motnjava očesne leče);
Cataract and glaucoma
katarakta in glavkom
Cataract Blurred vision
katarakta zamegljen vid
Cataract cortical, Cataract nuclear, Cataract subcapsular, Corneal erosion, Corneal abrasion,
kortikalna katarakta, nuklearna katarakta, subkapsularna katarakta, erozija roženice,
Cataract, accommodation disorders
katarakta, motnje akomodacije
Cataract, accomodation disorders
akomodacije
Cataract, blurred vision;
katarakta, zamegljen vid;
cataract, conjunctivitis
katarakta, konjunktivitis
Cataract, glaucoma, papilloedema
katarakta, glavkom, edem papile vidnega živca
Cataract, increased blood congestion in the eye, blurred vision
katarakta, povečana količina krvi v očesnih krvnih žilah, zamegljen vid,
cataract, ocular hyperaemia, vision blurred
katarakta, hiperemija očesa, zamegljen vid
Cataractogenic effects of palifermin cannot be excluded (see section 5.1).
Kataraktogenih učinkov palifermina ni mogoče izključiti (glejte poglavje 5.1).
Cataracts
katarakte,
Cataracts1
katarakte1
Categories have been assigned based on absolute frequencies in the clinical trial data.
Kategorije pogostnosti so bile določene na osnovi absolutne pogostnosti iz kliničnih preskušanj.
Categories have been assigned based on absolute frequencies in the clinical trial data.
Kategorije so določene glede na absolutne pogostnosti v podatkih kliničnih preskušanj.
Categories have been assigned based on absolute frequencies in the pooled clinical studies data.
Kategorije pogostnosti so določene na osnovi absolutnih pogostnosti pojavljanja iz podatkov, dobljenih iz zbranih kliničnih študij.
Catheter occlusion
Zapora katetra
Catheter related infection Catheter site infection Sepsis
katetrom povezane okužbe okužba mesta katetra sepsa
Catheter sepsis
epsa zaradi katetra
Catheter site haemorrhage
krvavitev na mestu katetra
Catheter site haemorrhage
krvavitev na mestu vstavitve katetra
Catheter site pain
bolečina na mestu vstavljenega katetra
Catheter site pain, injection site complaints (redness, hard lump, pain, swelling, irritation, rash, hives, leaking of fluid from the catheter into the tissue), inflammation of vein at injection site
bolečina na mestu vstavljenega katetra, zapleti na mestu injiciranja (rdečina, otrdlina, bolečina, otekanje, draženje, izpuščaj, koprivnica, uhajanje tekočine iz katetra v tkivo), vnetje vene na mestu injiciranja
Catheter site pain, injection site complaints (redness, hard lump, pain, swelling, irritation, rash, hives, leaking of fluid from the catheter into the tissue), inflammation of vein at injection site
bolečina na mestu vstavljenega katetra, zapleti na mestu injiciranja (rdečina, otrdlina, bolečina, otekanje, draženje, izpuščaj, koprivnica, uhajanje tekočine iz katetra v tkivo), vnetje vene na mestu injiciranja,
Catheter thrombosis, Vascular pseudoaneurysm
katetrska tromboza, vaskularni psevdoanevrizem
Catheter-related complications
Fylgikvillar tengdir æðalegg
catheter-related infection, systemic infection and local blood clot at the catheter site.
katetrom povezane okužbe, sistemska okužba in lokalni krvni strdek na mestu katetra.
cathode electrode: layers of polyisobutylene/silver chloride/carbon black composite material, silver foil, and electrically conductive adhesive tape
katodna elektroda: plasti kompozitnega materiala poliizobutilena/srebrovega klorida/sajasto črnega barvila, srebrna folija in električno prevoden lepilni trak;
cathode hydrogel: purified water, sodium chloride, sodium citrate, polyvinyl alcohol, anhydrous citric acid, cetylpyridinium chloride
katodni hidrogel: prečiščena voda, natrijev klorid, natrijev citrat, polivinilalkohol, brezvodna citronska kislina, cetilpiridinijev klorid;
Cationic medicinal products that are eliminated by renal tubular secretion (e.g., cimetidine) may interact with metformin by competing for common renal tubular transport systems.
Kationska zdravila, ki se izločajo z ledvično tubularno sekrecijo (npr. cimetidin), lahko vstopijo v interakcije z metforminom zaradi kompeticije za skupne tubularne transportne sisteme v ledvicah.
Cationic substances that are eliminated by renal tubular secretion (e.g. cimetidine) may interact with metformin by competing for common renal tubular transport systems.
Kationske snovi, ki se izločajo s tubularno sekrecijo (npr. cimetidin), lahko součinkujejo z metforminom zaradi tekmovanja za skupne ledvične tubulne prenašalne mehanizme.
Cats 2.5-7.5 kg
Mačke 2,5-7,5 kg
Cats 2.5–7.5 kg
Mačke 2,5 – 7,5 kg
Cats :
Mačke:
Cats above 8 weeks of age.
Mačke, starejše od 8 tednov.
Cats and dogs
Mačke in psi.
Cats and Dogs
mačke, psi
Cats and dogs
Psi in mačke
Cats and dogs from various breeds, age groups and weights were treated.
Zdravljeni so bili psi in mačke različnih pasem, starosti in telesnih mas.
Cats and dogs weighing 2.5 kg or less (Stronghold 15 mg spot-on solution for cats and dogs < 2.5 kg) Dogs weighing 2.6 kg–5.0 kg (Stronghold 30 mg spot-on solution for dogs 2.6–5.0 kg)
Mačke in psi, ki tehtajo 2,5 kg ali manj (Stronghold 15 mg kožni nanos, raztopina za mačke in pse < 2,5 kg)
Cats can develop diabetic remission, in which case the cat's own insulin production is regained and insulin dosing will need to be adjusted or ceased.
Pri mačkah lahko pride do remisije sladkorne bolezni, pri čemer začne ponovno nastajati dovolj endogenega insulina, zato bo treba odmerek eksogenega insulina prilagoditi ali ukiniti.
Cats can develop diabetic remission, in which case the cat's own insulin production is regained.
Pri mačkah lahko pride do remisije sladkorne bolezni, pri čemer začne ponovno nastajati dovolj endogenega insulina.
Cats in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms.
Mačke v endemičnih področjih dirofilarioze ali mačke, ki potujejo na taka področja, se lahko okužijo z odraslo srčno glisto.
Cats in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms.
Mačke, ki se nahajajo na področju, kjer se nahajajo prenašalci teh zajedavcev in mačke, ki na tako področje potujejo, se lahko infestirajo z odraslo obliko Dirofilarie immitis.
Cats in endemic areas, or those which have travelled to endemic areas, may be infected with adult heartworms.
Mačke, ki se nahajajo na področju, kjer se nahajajo prenašalci teh parazitov in mačke, ki na tako področje potujejo, se lahko infestirajo z odraslo obliko Dirofilarie immitis.
Cats in the household should be treated with a veterinary medicinal product authorised for use in that species.
Mačke v gospodinjstvu zdravimo z zdravilom, ki je odobreno za uporabo pri tej živalski vrsti.
Cats in the household should only be treated with a veterinary medicinal product authorised for use in that species.
Mačke v istem gospodinjstvu je potrebno tretirati samo s sredstvom za uporabo v veterinarski medicini, ki je ustrezno za uporabo pri mačkah.
Cats in the household should only be treated with a veterinary medicinal product authorised for use in that species.
Mačke v istem gospodinjstvu je potrebno tretirati samo s zdravilom za uporabo v veterinarski medicini, ki je ustrezno za uporabo pri mačkah.
Cats infected with adult heartworms tolerated up to 3 times the maximum exposure dose (i.e. up to 9 times the recommended dose), every 4 weeks for 3 treatments, without any adverse effects.
Mačke, infestirane z odraslimi srčnimi glistami, so brez pojava neželenih učinkov prenašale do 3-kratni maksimalni odmerek (to je do 9-kratni priporočeni odmerek), vsake 4 tedne, trikrat.
Cats may rarely show a slight scaling of their skin, temporary redness and itching or temporary hair loss at the application site.
Redko je pri mačkah mogoče opaziti rahlo luščenje kože, kratkotrajno rdečino in srbenje ali kratkotrajno izpadanje dlake na mestu nanosa.
Cats should be given a single oral treatment prior to orthopaedic surgery.
Mačkam je treba pred ortopedskim operativnim posegom dati enkratni peroralni odmerek.
Cats weighing 2.6–7.5 kg.
Mačke s telesno maso 2,6–7,5 kg.
Cats weighing 7.6–10.0 kg.
Mačke s telesno maso 7,6–10,0 kg.
Cats, ferrets
Mačke, beli dihurji
Cats: After administration of 40 micrograms dexmedetomidine/kg bw intramuscularly concurrently with 5 mg ketamine/kg bw to cats, the maximum concentration of dexmedetomidine increased twofold but there was no effect on T max.
Mačke: Po intramuskularni uporabi 40 mikrogramov deksmedetomidina/kg telesne teže skupaj s 5 mg ketamina/kg telesne teže se je najvišja koncentracija povečala dvakrat, vendar ni bilo učinka na Tmax.
Cats: After administration of 40 micrograms dexmedetomidine/kg bw intramuscularly concurrently with 5 mg ketamine/kg bw to cats, the maximum concentration of dexmedetomidine increased twofold but there was no effect on Tmax.
Mačke: Po intramuskularnem dajanju 40 mikrogramov deksmedetomidina/kg telesne mase skupaj s 5 mg ketamina/kg telesne mase se je najvišja koncentracija dvakratno povečala, vendar ni bilo učinka na Tmax.
Cats: as vaccination is contra-indicated in the symptomatic phase of FeLV/FIV infections, the effect of VIRBAGEN OMEGA on cat vaccination has not been evaluated.
Mačke: ker je cepljenje v simptomatski fazi okužbe s FeLV/FIV kontraindicirano, vpliv VIRBAGEN OMEGA na cepljenje mačk ni ocenjen.
CATS: In cases of overdosage, or if the effects of dexmedetomidine become potentially life- threatening, the appropriate antagonist is atipamezole, administered by intramuscular injection, at the following dose: 5 times the initial dose dexmedetomidine in micrograms/kg bw.
MAČKE: V primeru prevelikega odmerjanja, ali če postanejo učinki deksmedetomidina potencialno nevarni za življenje, uporabite atipamezol v obliki intramuskularne injekcije v naslednjem odmerku: 5-kratni prvotni odmerek deksmedetomidina v mikrogramih/kg telesne teže.
Cats: In cases of overdosage, or if the effects of dexmedetomidine become potentially life-threatening, the appropriate antagonist is atipamezole, administered by intramuscular injection, at the following dose: 5 times the initial dose dexmedetomidine in micrograms/kg bw.
Mačke: V primeru prevelikega odmerjanja, ali če postanejo učinki deksmedetomidina potencialno nevarni za življenje, uporabite atipamezol v obliki intramuskularne injekcije v naslednjem odmerku: 5-kratni prvotni odmerek deksmedetomidina v mikrogramih/kg telesne teže.
Cats: Post-operative pain: single subcutaneous injection.
Mačke: Pooperativna bolečina: enkratna podkoţna injekcija Pred uporabo preberite navodilo za uporabo.
Cats: Post-operative pain: single subcutaneous injection.
Mačke: Pooperativna bolečina: enkratna podkožna injekcija
Cats: Subcutaneous
Ma ke: Subkutana upočraba
Cats: Subcutaneous use
Ma ke: Subkutana upočraba
Cats: The recommended dose is 25 mg indoxacarb/kg body weight, equivalent to 0.128 ml/kg body weight.
Mačke: Priporočeni odmerek je 25 mg indoksakarba/kg telesne teže, kar ustreza 0,128 ml/kg telesne teže.
Cattle
injekcija
Cattle & Pigs
Goveda in prašiči
Cattle (calves and young cattle)
Govedo (teleta in mlado govedo)
Cattle (calves and young cattle) and dogs
Govedo (teleta, mlado govedo) in psi
Cattle (calves and young cattle) and pigs
Govedo (teleta in mlado govedo) in prašiči
Cattle (calves and young cattle) and pigs.
Govedo (teleta in mlado govedo) in prašiči
Cattle (calves and young cattle) and pigs.
Govedo (teleta in mlado govedo) in prašiči.
Cattle (calves and young cattle)\ Dogs
Govedo (teleta in mlado govedo) Psi
Cattle (cows and heifers)
Govedo (krave in teleta)
Cattle (cows and heifers).
govedo (krave in telice)
Cattle (dairy cows and heifers)
Govedo (krave molznice in telice)
Cattle (lactating dairy cows)
Govedo (krave v obdobju laktacije).
Cattle and dogs
Govedo in psi
Cattle and horses.
Govedo in konji
Cattle and horses.
Govedo in konji.
Cattle and pigs
goveda in prašiči
Cattle and pigs.
Govedo in prašiči
Cattle and pigs.
Govedo in prašiči.
Cattle and sheep
Goveda in ovce
Cattle and Sheep
Govedo in ovce in govedo
Cattle and sheep
Ovce in govedo
Cattle and sheep: for subcutaneous use.
Govedo in ovce: –subkutano.
Cattle Box
Govedo Škatla
Cattle from 3 months of age:
Govedo od 3 mesecev starosti:
Cattle from 6 weeks of age: injection of two doses of 1 ml, administered with an interval of approximately 3 weeks.
Govedo od 6 mesecev starosti: dva odmerka po 1 ml v razmiku približno 3 tednov.
Cattle Subcutaneous use.
Subkutano dajanje.
Cattle weighing more than 250 kg and pigs weighing more than 125 kg will need to have the dose divided and injected at more than one site.
Pri govedu, ki tehta več kot 250 kg, in prašičih, ki tehtajo več kot 125 kg, je treba odmerek razdeliti in ga injicirati na več kot enem mestu.
Cattle,
Govedo, ovce
Cattle,
Govedo.
Cattle, and horses
goveda in konji
Cattle, Horse and Pig
Govedo,
Cattle, horses and pigs
Goveda, prašiči in konji
Cattle, Pigs
Goveda in prašiči
Cattle, pigs and horses
Goveda, prašiči in konji.
Cattle, pigs and horses
prašiči in konji
Cattle, pigs and horses
Prašiči:
Cattle, pigs and horses.
Govedo, prašiči in konji
Cattle, pigs, horses
Govedo, prašiči in konji.
Cattle, sheep
goveda, ovce
Cattle, sheep and pigs
Govedo, ovce
Cattle, sheep and pigs
Govedo, ovce, prašiči
Cattle, sheep and pigs
in prašiči
Cattle, sheep, and pigs
Govedo, ovce in prašiči
Cattle.
Govedo
Cattle:
Govedo: podkožna
Cattle: Can be used during pregnancy and lactation.
Govedo: lahko se uporablja v obdobju brejosti in laktacije.
Cattle: Can be used during pregnancy.
Govedo: Zdravilo lahko uporabljate med brejostjo.
Cattle: Can be used during pregnancy.
Govedo: Zdravilo se lahko uporablja med brejostjo.
Cattle: For subcutaneous use.
Govedo: za subkutano uporabo.
Cattle: intramuscular use.
Govedo: intramuskularna uporaba.
Cattle: intravenous or subcutaneous Pigs: intramuscular
Goveda: intravenska podkožna, prašiči: intramuskularna
Cattle: meat and
Govedo: meso in
Cattle: meat and offal: 15 days
Goveda: meso in organi: 15 dni
Cattle: meat and offal: 15 days
Govedo: meso in organi: 15 dni
Cattle: meat and offal: 15 days; milk: 5 days
Goveda: meso in organi: 15 dni; mleko: 5 dni
Cattle: meat and offal: 15 days; milk: 5 days
Govedo: meso in organi: 15 dni, mleko: 5 dni.
Cattle: meat and offal: 15 days; milk: 5 days
Govedo: meso in organi: 15 dni; mleko: 5 dni
Cattle: Meat and offal: 15 days; Milk: 5 days Pigs: Meat and offal: 5 days
Govedo: Meso in organi: 15 dni; Mleko: 5 dni Prašiči: Meso in organi: 5 dni
Cattle: meat and offal: 15 days; milk: 5 days.
Govedo: meso in organi: 15 dni; mleko: 5 dni
Cattle: meat and offal: 15 days; milk: 5 days.
Govedo: meso in organi: 15 dni; mleko: 5 dni.
Cattle: SC ,IV
Govedo: s.c., i.v.
Cattle: SC or IV
Goveda: s.c. ali i.v.
Cattle: SC or IV injection.
Goveda: s.c. ali i.v. injekcija
Cattle: SC or IV injection.
Goveda: s.c. ali i.v. injekcija.
Cattle: SC or IV injection.
Govedo s.c. ali i.v. injekcija
Cattle: SC or IV.
Govedo: s.c. ali i.v.
Cattle: Single S.C. or I.V. injection.
Goveda: Enkratna s.c. ali i.v. injekcija
Cattle: Single SC injection.
Goveda: Enkratna s.c. injekcija
Cattle: Single subcutaneous or intravenous injection.
Goveda: Enkratna podkožna ali intravenska injekcija
Cattle: subcutaneous or intravenous use Pigs: intramuscular use
Goveda: subkutana ali intravenska uporaba Prašiči: intramuskularna uporaba